Healthcare provider profile · identity verified

Aaron Garman, M.D.

Family Practice · BEULAH, ND · NPI 1457339939

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	309	61
Losartan Potassium	Losartan Potassium	288	63
Amlodipine Besylate	Amlodipine Besylate	271	75
Atorvastatin Calcium	Atorvastatin Calcium	264	65
Lisinopril	Lisinopril	261	63
Pantoprazole Sodium	Pantoprazole Sodium	258	55
Rosuvastatin Calcium	Rosuvastatin Calcium	229	63
Metoprolol Succinate	Metoprolol Succinate	226	46
Metformin Hcl	Metformin Hcl	203	46
Potassium Chloride	Potassium Chloride	196	34
Hydrochlorothiazide	Hydrochlorothiazide	177	44
Tamsulosin Hcl	Tamsulosin Hcl	167	43
Eliquis	Apixaban	162	24
Furosemide	Furosemide	136	36
Sertraline Hcl	Sertraline Hcl	124	21
Gabapentin	Gabapentin	112	22
Myrbetriq	Mirabegron	103	suppressed
Omeprazole	Omeprazole	101	29
Duloxetine Hcl	Duloxetine Hcl	95	15
Citalopram Hbr	Citalopram Hydrobromide	88	18
Synthroid	Levothyroxine Sodium	87	11
Simvastatin	Simvastatin	84	22
Allopurinol	Allopurinol	81	19
Spironolactone	Spironolactone	79	19
Xarelto	Rivaroxaban	78	suppressed
Trazodone Hcl	Trazodone Hcl	77	22
Clopidogrel	Clopidogrel Bisulfate	76	21
Zolpidem Tartrate	Zolpidem Tartrate	74	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	15
Carvedilol	Carvedilol	71	16
Albuterol Sulfate Hfa	Albuterol Sulfate	69	26
Metoprolol Tartrate	Metoprolol Tartrate	67	19
Hydromorphone Hcl	Hydromorphone Hcl	65	suppressed
Warfarin Sodium	Warfarin Sodium	60	14
Glipizide	Glipizide	56	14
Finasteride	Finasteride	55	suppressed
Montelukast Sodium	Montelukast Sodium	55	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	14
Novolog Flexpen	Insulin Aspart	51	11
Celecoxib	Celecoxib	49	15
Pravastatin Sodium	Pravastatin Sodium	46	12
Donepezil Hcl	Donepezil Hcl	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	suppressed
Metformin Hcl Er	Metformin Hcl	45	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	43	11
Glyxambi	Empagliflozin/Linagliptin	43	suppressed
Ozempic	Semaglutide	43	suppressed
Alendronate Sodium	Alendronate Sodium	41	suppressed
Ezetimibe	Ezetimibe	41	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	30
Tresiba Flextouch U-200	Insulin Degludec	40	suppressed
Ventolin Hfa	Albuterol Sulfate	40	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	12
Famotidine	Famotidine	37	11
Prednisone	Prednisone	37	23
Atenolol	Atenolol	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Clonazepam	Clonazepam	33	12
Lorazepam	Lorazepam	33	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	21
Jardiance	Empagliflozin	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Levemir	Insulin Detemir	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Ibandronate Sodium	Ibandronate Sodium	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Cephalexin	Cephalexin	23	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Cefdinir	Cefdinir	21	18
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fentanyl	Fentanyl	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	13
Baclofen	Baclofen	20	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Glyburide	Glyburide	19	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	18	suppressed
Torsemide	Torsemide	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Divalproex Sodium	Divalproex Sodium	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Nitroglycerin	Nitroglycerin	13	13
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Trospium Chloride Er	Trospium Chloride	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error